Differential phosphorylation of PKR associates with deregulation of eIF-2α phosphorylation and altered growth characteristics in 3T3-F442A fibroblasts

Molecular and Cellular Biochemistry

Volumn 198, Issue 1-2, 1999, Pages 7-17

  Woldehawariat, Girma ^a   Nekhai, Sergei ^b   Petryshyn, Raymond ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cell proliferation; dRF; eIF 2 ; PKR

Indexed keywords

INITIATION FACTOR 2; PROTEIN KINASE; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL DENSITY; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CULTURE MEDIUM; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; IMMUNOBLOTTING; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 0032829651     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006978622240     Document Type: Article

References (58)

1. Pestka S, Langer JA, Zoon KC: Interferons and their actions. Annu Rev Biochem 56: 727-777, 1987
2. Sen GC, Lengyel P: The interferon system. A bird's eye view of its biochemistry. J Biol Chem 267: 5017-5020, 1992
3. De Maeyer E, De Maeyer-Guignard J: Interferons and other regulatory cytokines. Wiley, New York, 1988
4. Clemens JM, Tilleray VJ, James R: Relationship of cellular oncogene expression to inhibition of growth and induction of differentiation of Daudi cells by interferons or TPA. J Cell Biochem 38: 251-259, 1988
5. Jonak GJ, Knight E: Selective reduction of c-myc RNA in Daudi cells by human Beta-interferon. Proc Natl Acad Sci USA 81: 1747-1750, 1984
6. Einat M, Resnitzky D, Kimchi A: Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor. Proc Natl Acad Sci USA 82: 7608-7612, 1985
7. Souslau G, Bogucki AR, Gillespie D, Hubble HR: Phosphoproteins altered by antiproliferative doses of human interferon-beta in a human bladder carcinoma cell line. Biochem Biophys Res Commun 119: 941-948, 1984
8. Samuel CE, Flessate DM, Grenne JJ, Chang EH, Friedman RM: Presisting revertants after interferon treatment of oncogene-transformed cells. In: W.E. Stewart II, H. Schellekems (eds). The Biology of the Interferon System.Elsevier, Amsterdam, 1984, pp. 327-332
9. Harda H, Kitagawa M, Tanka N, Yamamoto H, Harda K, Ishihara M, Taniguchi T: Antioncogenic potentials of interferon regulatory factors -1 and -2. Science 259: 971-974, 1993
10. Koromilas AE, Roy S, Barber GN: Malignant transformation by a mutant of the IFN-inducible dsRNA dependent protein kinase. Science 257: 1685-1689, 1992
11. Squire J, Meurs EF, Chong KL: Localization of the human interferon induced, dsRNA activated p68 kinase gene (PKR) to chromosome 2p21-p22. Genomics 16: 768-776, 1993
12. Lengyel PL: Tumor-suppressor genes: News about the interferon connection. Proc Natl Acad Sci USA 90: 5893-5895, 1993
13. Kalvakolanu DV, Borden EC: An overview of the interferon system: Signal transduction and mechanism of action. Cancer Invest 14: 25-53, 1996
14. Sonenberg N: Translational factors as effectors of cell growth and tumorigenesis. Curr Opin Cell Biol 5: 955-960, 1993
15. De Haro C, Mendez R, Santoyo J: The eIF-2α kinase and the control of protein synthesis. FASEB J 10: 1378-1387, 1996
16. Lebleu B, Sen GC, Shaila S, Cabrer B, Lengyel PL: Interferon, double-stranded RNA and protein phosphorylation. Proc Natl Acad Sci USA 73: 3107-3111, 1976
17. Jarmillo ML, Abraham N, Bell JC: The interferon system: A review with emphasis on the role of PKR on growth control. Cancer Invest 13: 327-338, 1995
18. Hunter T, Hunt T, Jackson RJ, Robertson HD: The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. J Biol Chem 250: 409-417, 1975
19. Farrell PJ, Balkow K, Hunt T, Jackson RJ, Trachsel H: Phosphorylation of initiation factor eIF-2 and control of reticulocyte protein synthesis. Cell 11: 187-200, 1977
20. Petryshyn RA, Levin DH, London IM: Double-stranded RNA-dependent eIF-2α protein kinase. Methods Enzymol 99: 346-362, 1983
21. Matts RL, London IM: The regulation of initiation of protein synthesis by phosphorylation of eIF-2(α) and the role of reversing factor in the recycling of eIF-2. J Biol Chem 259: 6708-6711, 1984
22. Rowlands AG, Panniers R, Henshaw EC: The catalytic mechanisms of guanine nucleotide exchange factor action and competitive inhibition by phosphorylation eukaryotic initiation factor 2. J Biol Chem 263: 5526-5533, 1988
23. London IM, Levin DH, Matts RL, Thomas NSB, Petryshyn RA, Chen JJ: The Enzymes. In: P.D. Boyer, E.G. Krebs (eds). Academic Press, New York, 18: 359-380, 1987
24. Barber GN, Wambach M, Thompson S, Jagus R, Katze MG: Mutants of the RNA-dependent protein kinase (PKR) lacking dsRNA binding domain 1 can act as a transdominant inhibitors and induce malignant transformation. Mol Cell Biol 15: 3138-3146, 1995
25. Donze O, Jagus R, Koromilas AK, Hershey JWB, Sonenberg N: Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14: 3828-3834, 1995
26. Yang Y-Y, Reis LFL, Pavlovic J, Aguzzi A, Schafer R, Kumar A, Williams BRG, Aguet M, Weissmann C: Deficient signaling in mice devoid of double-stranded RNA dependent protein kinase. EMBO J 114: 6095-6106, 1995
27. Williams BRG: Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Regulations of Transcription and Translation 25: 509-513, 1997
28. Green H, Kehinde O: Formation of normally differentiated subcutaneous fat pads by an established predispose cell line. J Cell Physiology 101: 169-172, 1979
29. Green H, Kehinde O: Spontaneous changes leading to increased adipose conversion in 3T3 cells. Cell 7: 105-113, 1976
30. Petryshyn RA, Chen J-J, London IM: Growth related expression of a double-stranded RNAdependent protein kinase in 3T3-F442A cells. J Biol Chem 259: 14736-14742, 1984
31. Petryshyn RA, Chen J-J, London IM: Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells. Proc Natl Acad Sci USA 85: 1427-1431, 1988
32. Judware R, Petryshyn RA: Partial characterization of a cellular factor that regulates the double-stranded RNA-dependent eIF-2α kinase in 3T3-F442A fibroblasts. Mol Cell Biol 11: 3259-3267, 1991
33. Judware R, Petryshyn RA: Mechanism of action of a cellular inhibitor of the dsRNAdependent protein kinase from 3T3-F442A cells. J Biol Chem 267: 21685-21690, 1992
34. Li J, Yu Z-P, Slomiany DJ, Petryshyn RA: Int J Oncol 11: 1-11, 1997
35. Warrener P, Petryshyn R: Phosphorylation and protedytic degradation of nucleolin from 3T3F442A cells. Biochem Biophys Res Commun 180: 716-723, 1991
36. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
37. Laemmli VK: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature (London) 227: 680-685, 1975
38. Maurides AP, Akkaraju GR, Jagus R: Evaluation of protein phosphorylation state by a combination of vertical slab gel isoelectric focusing and immunoblotting. Anal Biochem 183: 144-151, 1989
39. Proud CG: PKR: A new name and new roles. TIBS 20: 241-246, 1995
40. Pain VM: Initiation of protein synthesis in eukaryotic cells. Eur J Biochem 236: 747-771, 1996
41. Hershey JWB: Translational control in mammalian cells. Annu Rev Biochem 60: 717-755, 1991
42. Petryshyn RA, Chen J-J, Danley L, Matts RL: Effect of interferon on protein translation during growth states of 3T3 cells. Arch Biochem Biophys 326: 290-297, 1996
43. Meurs EF, Galabru J, Barber GN: Tumor suppressor function of the interferon-induced double-stranded RNA activated protein kinase. Proc Natl Acad Sci USA 90: 232-236, 1993
44. Benkirane M, Neuveut C, Chun RF, Smith SM, Samuel CE, Gatignol A, Jeang KT: Oncogenic potential of TAR RNA binding protein RTBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J 16: 611-624, 1997
45. Akkaraju GR, Whitaker-Dowling P, Younger JS, Jagus R: Vaccina specific kinase inhibitory factors prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate. J Biochem Chem 264: 10321-10325, 1989
46. Kitajewski J, Schneider RJ, Safer B, Munemitsu SM, Samuel CE, Thimmappaya B, Shenk T: Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2- kinase. Cell 45: 195-200, 1986
47. Davies M, Elroy-Stein O, Jagus R, Moss B, Kaufman RJ: The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 66: 1943-1950, 1992
48. Mundschau LJ, Faller DV: Oncogenic ras induces an inhibitor of double-stranded RNAdependent eurkaryotic initiation factor 2α-kinase activation. J Biol Chem 267: 23092-23098, 1992
49. Barber GN, Thompson S, Lee TG, Strom T, Jagus R, Darveau A, Katze MG: The 58 kilodalton inhibitor of the interferon-induced double-stranded RNA activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc Natl Acad Sci USA 91: 4278-4282, 1994
50. Montine KS, Henshaw EC: Serum growth factors cause rapid stimulation of protein synthesis and dephosphorylation of eIF-2α in serum deprived Ehrlich cells. Biochem Biophys Acta 10: 282-288, 1989
51. Kimchi A: Cytokine triggered molecular pathways that control cell cycle arrest. J Cell Biochem 50: 1-9, 1992
52. Melamed D, Tiefenbrun N, Yarden A, Kimchi A: Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells. Mol Cell Biol 13: 5255-5265, 1993
53. 0-like arrest. Mol Cell Biol 16: 3934-3944, 1996
54. Hobeika AC, Subramaniam PS, Johnson HM: IFN alpha induces the expression of the cyclindependent kinase inhibitor p21 in human prostate cancer cells. Oncogene 14: 1165-1170, 1997
55. Hunter T: Oncoprotein networks. Cell 88: 333-346, 1997
56. Maran A, Maitra RK, Kumar A, Dong BH, Xia W, Li GY, Williams BR, Torrence PF, Silverman RH: Blockage of NF-KP signaling by selective ablation of an mRNA target by 25A antisense chimeras. Science 265: 789-792, 1994
57. Koromilas AE, Cantin C, Craig AWB, Jagus R, Hiscott J, Sonenberg N: The interferon inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin K gene. J Biol Chem 270: 25426-25434, 1995
58. Mundshau LJ, Faller DV: Platelet-derived growth factor signal transduction through the interferon-inducible PKR. Immediate early gene induction. J Biol Chem 270: 3100-3106, 1995